Related Experiment Video
Updated: Mar 15, 2026

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Acute severe ulcerative colitis: from pathophysiology to clinical management
Pieter Hindryckx1,2,3, Vipul Jairath4,3, Geert D'Haens2,3
1Department of Gastroenterology, University Hospital of Ghent, De Pintelaan 185, 9000 Ghent, Belgium.
Acute severe ulcerative colitis (ASUC) is a serious condition requiring prompt hospitalization and treatment. Management includes corticosteroids, with rescue therapies like ciclosporin or infliximab for non-responders, and surgery if medical treatment fails.
Area of Science:
- Gastroenterology
- Immunology
- Internal Medicine
Background:
- Ulcerative colitis is a chronic inflammatory bowel disease affecting the colon and rectum.
- A dysregulated immune response in genetically susceptible individuals triggers the disease.
- Severe flares necessitate hospitalization and intensive management.
Purpose of the Study:
- To review the pathophysiology of acute severe ulcerative colitis (ASUC).
- To outline modern clinical management strategies for ASUC.
- To provide a comprehensive overview of ASUC from disease onset to treatment outcomes.
Main Methods:
- Review of current medical literature on ASUC.
- Analysis of diagnostic criteria and treatment protocols.
- Synthesis of evidence-based recommendations for ASUC management.
Main Results:
- ASUC is a life-threatening condition requiring immediate medical attention.
- First-line treatment involves intravenous corticosteroids.
- Rescue therapies (ciclosporin, infliximab) and colectomy are options for refractory cases.
Conclusions:
- Early recognition and prompt management are crucial for improving outcomes in ASUC.
- A stepwise approach to treatment, from corticosteroids to rescue therapies or surgery, is essential.
- Ongoing monitoring of clinical and laboratory parameters guides treatment decisions in ASUC.
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...

